Effective Vendor Oversight in Orphan Drug Development
Effective Vendor Oversight in Orphan Drug Development Optimizing Vendor Oversight in Rare Disease Clinical Trials Why Vendor Oversight Is Critical in Orphan Drug Trials Vendor oversight is a core responsibility of sponsors conducting clinical trials—and in rare disease programs, this function becomes even more critical. Given the complexity of orphan drug development, sponsors often engage…
Read More “Effective Vendor Oversight in Orphan Drug Development” »